DRI Healthcare Trust (TSE:DHT.UN) Trading 0.6% Higher After Analyst Upgrade

DRI Healthcare Trust (TSE:DHT.UN)’s stock price rose 0.6% on Friday after Royal Bank of Canada raised their price target on the stock from C$17.00 to C$18.00. Royal Bank of Canada currently has an outperform rating on the stock. DRI Healthcare Trust traded as high as C$12.68 and last traded at C$12.64. Approximately 12,456 shares changed hands during trading, a decline of 69% from the average daily volume of 40,564 shares. The stock had previously closed at C$12.57.

Several other research firms have also recently issued reports on DHT.UN. National Bankshares raised their target price on shares of DRI Healthcare Trust from C$18.00 to C$18.50 and gave the stock an “outperform” rating in a research report on Thursday. CIBC lifted their price target on shares of DRI Healthcare Trust from C$16.00 to C$17.00 and gave the stock an “outperform” rating in a research note on Thursday. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of C$18.07.

DRI Healthcare Trust Trading Up 0.6%

The firm has a fifty day simple moving average of C$11.66 and a 200 day simple moving average of C$11.99.

About DRI Healthcare Trust

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.